QSI · Quantum-Si Inc

Track QSI — free

$0.77 +0.01 (+0.66%) At close · Sep 4

Rebalance outlook locked

Market Cap

$167.67M

218.88M

Up next

Next earnings call

Nov 16, 2026 Est · unconfirmed · in 10 wks

Latest filing: 10-Q

filed Aug 13, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 114 metrics

Revenue (TTM)

$1.60M

Trailing 12 months

Net income (TTM)

−$98.52M

Trailing 12 months

Revenue growth YoY

-41.8%

Year over year

Operating margin

-6,887.8%

Trailing 12 months

P / E (TTM)

—

Trailing earnings

FCF yield

—

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+18.6%

Year over year · more shares

Price change (1Y)

-28.4%

Trailing year

Short interest

6.5%

Latest settlement · 4.7 days to cover

View all 114 metrics

Equibles Rating

blended score · not investment advice

Overall

Sell

SellHoldBuy

Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High

Market backdrop VIX 14.5 · calm Equity put/call 0.58

Technical

price trend

Sell

50 / 200-day cross No cross

Price vs 200-day avg −23%

below

Price vs 50-day avg −5%

below

RSI (14) 47

neutral

MACD trend Positive

52-week position 3%

near low

Momentum

relative strength

Very Weak

1-month return −6%

trailing

6-month return −19%

trailing

YTD return −30%

this year

Relative strength −34%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $1 › 200d $1 — 200d above 50d

Institutional flow Distributing

-11% holders QoQ · +26 funds added

Insider flow Distributing

Net -$71.2K over 90 days · 100% sells

Short interest Falling

6.52% of float · ▼ -7.4% MoM · 4.7 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

141 holders — mid 3-yr range

Squeeze score 52

elevated · 0–100

Fundamentals

Fair

Revenue growth −20%

Y/Y

Gross margin 47%

contracting

EPS growth +28%

Y/Y

Free cash flow $-97.2M

Quant / Vol

risk profile

Very High

Volatility 92%

annualized · 1-yr

Max drawdown −73%

past year

ATR 6.7%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed Aug 13, 2026

Revenue · full year 2026 Initiated $1M

prior FY $2.44M midpoint −58.9% Y/Y

Prior guidance period ended · from the 8-K filed Aug 7, 2024

Revenue · full year 2024 $3.7M – $4.2M

Guided vs delivered · last 1 settled

Revenue full year 2024

guided $3.7M – $4.2M

guided $3.7M – $4.2M $3.06M Miss −22.6%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell

3 · 2 · 1

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−23% Bearish

Price vs 50-day avg

−5% Bearish

RSI (14)

47 Neutral

MACD trend

Positive Bullish

52-week position

3% Bearish

Market signals — smart money & positioning

Bearish · 2 of 6

Trend (MA cross) No cross

50d $1 › 200d $1 — 200d above 50d

Institutional flow Distributing

-11% holders QoQ · +26 funds added

Insider flow Distributing

Net -$71.2K over 90 days · 100% sells

Short interest Falling

6.52% of float · ▼ -7.4% MoM · 4.7 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

141 holders — mid 3-yr range

Price context

position in its 52-week range

Range low $1 Now $1 · 3% Range high $3

vs 200-day avg -23% vs 50-day avg -5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Devices — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
QSI Quantum-Si Inc this stock	$167.67M	-30.4%	-20.3%	—	6.5%
ABT Abbott Laboratories	$188.69B	-13.5%	+5.7%	30.3	1.2%
MDT Medtronic plc	$120.46B	-2.0%	+8.4%	23.2	1.1%
SYK Stryker Corp	$116.27B	-13.8%	+11.2%	31.4	1.8%
BSX Boston Scientific Corp	$69.27B	-49.9%	+12.5%	19.4	1.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

141

% held: 24.6%
Net QoQ: -10.3M sh
Top holder: VANGUARD CAPITAL MANAGEME…

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Falling

Shares short

14.3M

Days to cover: 4.7d
Change: -1.1M sh

View

Short Volume

Short vol %

60%

As of: Sep 4, 2026

Short Total

View

Fails to Deliver

FTD shares

4.0K

Value: $3.4K
As of: Aug 13, 2026

View

Off-Exchange

Off-exchange %

72.1%

Week of: Jul 27, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$71.2K

Buyers / Sellers: 0 / 4

Buyers Sellers

View

Financials

Revenue (FY)

$2.4M

Net income (FY): $-101.3M
EPS diluted: $-0.51

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 13, 2026
This year: 11

View

Proposed Sales

Value

$14.5K

Shares: 15.6K
Filed: Jun 24, 2026

View

Earnings & Events

Earnings Calls

Last call

Aug 13, 2026

View

Investor Relations

Upcoming events

View

Performance

	5D	20D	120D	MTD	YTD
QSI	-1.8%	-5.9%	-18.9%	+0.0%	-30.4%
SPY	+0.1%	-0.4%	+15.1%	+0.4%	+12.9%
vs SPY	-1.9%	-5.5%	-34.0%	-0.4%	-43.3%

Key facts CIK 1816431 CUSIP 74765K105 13F (30d) 82 filings 82 filers Visit website Investor relations

QSI · Quantum-Si Inc

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance